Treatment preference in hypochondriasis.
Promising cognitive-behavioral and medication treatments for hypochondriasis are in the early stages of evaluation. Little is known about the treatment preferences and opinions of individuals seeking help for this problem. In this exploratory study, 23 volunteers from the community with a DSM-IV diagnosis of hypochondriasis were recruited through a newspaper advertisement. Participants were presented with a survey which included balanced descriptions of both a medication and a cognitive-behavioral treatment for intense illness concerns (hypochondriasis). The brief descriptions of the treatments discussed the time commitment required as well as the major advantages and disadvantages of each. Results showed that, relative to medication treatment, cognitive-behavioral treatment was predicted to be more effective in both the short and long terms and was rated as more acceptable. Psychological treatment was indicated as the first choice by 74% of respondents, medication by 4%, and 22% indicated an equal preference. Forty-eight percent of respondents would only accept the psychological treatment.
Walker
J
J
Department of Clinical Health Psychology, University of Manitoba, Canada. jwalker@cc.umanitoba.ca
Vincent
N
N
Furer
P
P
Cox
B
B
Kjernisted
K
K
D000328:Adult; D001008:Anxiety Disorders / Q000150:complications; D002170:Canada; D015928:Cognitive Behavioral Therapy; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000150:complications / Q000188:drug therapy / Q000523:psychology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000523:psychology* / Q000706:statistics & numerical data; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D010865:Pilot Projects; D011795:Surveys and Questionnaires; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014149:Tranquilizing Agents